Western University of Health Sciences

WesternU Students Mentor Rural Oregon Youth in MIKE Health Pipeline

Image
WesternU Students Mentor Rural Oregon Youth in MIKE Health Pipeline

Lebanon – October 15, 2026 -- Medical and physical therapy students at Western University of Health Sciences (WesternU) in Oregon are mentoring rural high schoolers twice a month through the MIKE Program, a workforce-pipeline pilot that began in Sweet Home in 2020.

Sweet Home request in 2018 led to the 2020 rural pilot

MIKE is a non-profit that educates and mentors youth on healthy living and health care careers. It started in the Portland area and now serves urban and rural communities across Oregon and Southwest Washington. Sweet Home asked in 2018 for a peer-to-peer program linking its high school with the medical school. The partnership launched two years later as a pilot for rural communities.

Students from the Heatherington College of Osteopathic Medicine (HCOM) and the College of Health Sciences-Northwest (CHS-Northwest) volunteer as mentors. Physical therapy students have since joined the original medical student cohort.

WesternU Hosts Second A.P. Howells Lectureship, Launches New Honors

Image
WesternU Hosts Second A.P. Howells Lectureship, Launches New Honors

Lebanon, Ore. – September 23, 2026 -- Western University of Health Sciences Heatherington College of Osteopathic Medicine (WesternU HCOM) hosted its second annual A.P. Howells, DO, Endowed Lectureship on Aug. 29-30, 2026, training physicians in the Fascial Distortion Model (FDM) for musculoskeletal treatment.

Todd Capistrant, DO, led hands-on FDM training combining online modules with supervised clinical practice

Capistrant, a Medical Director at Foundation Health Partners since 2013 and a board-certified family medicine physician, taught participants to identify fascial distortion patterns and apply introductory osteopathic manipulative treatment techniques. He emphasized that patient activity levels remain a stronger predictor of long-term health outcomes than pharmaceutical interventions for reducing heart disease, stroke, dementia and cancer risk.